Amgen, Cytokinetics Report Mixed Results for Heart Failure Drug TheStreet.com But heart failure patients treated with the highest dose of the drug, known as omecamtiv mecarbil, were able to breathe easier and showed sufficient, additional clinical improvements for Amgen and Cytokinetics to call the overall study outcome ... |
